ALLIE HUNT: Open Payments
NPI 1225768922 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,055 in 105 payments from 17 companies in 2025. Trend: 2023 $1,729 · 2024 $2,099 · 2025 $2,055
Food & beverage: $2,055
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $683 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $197 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $160 |
| Janssen Biotech, Inc. | 8 | $157 |
| Ardelyx, Inc. | 10 | $156 |
| Aimmune Therapeutics, Inc. | 6 | $109 |
| E.R. Squibb & Sons, L.L.C. | 1 | $105 |
| GENZYME CORPORATION | 4 | $90 |
| Lilly USA, LLC | 4 | $71 |
| Madrigal Pharmaceuticals | 3 | $63 |
Products named: RINVOQ, LINZESS, ENTYVIO, XIFAXAN, TREMFYA, IBSRELA, DUPIXENT, ZENPEP.
Industry payments across TN — which companies pay providers there.
